Experienced in Erythema Multiforme

Dr. Michael C. Stephens

Internal Medicine
2700 Se Stratus Ave, Suite 403, 
Mcminnville, OR 
Experienced in Erythema Multiforme
2700 Se Stratus Ave, Suite 403, 
Mcminnville, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Stephens is a primary care provider, practicing in Internal Medicine in Mcminnville, Oregon. Dr. Stephens is rated as an Experienced provider by MediFind in the treatment of Erythema Multiforme. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Colitis, Kidney Transplant, and Endoscopy.

His clinical research consists of co-authoring 68 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Erythema Multiforme.

Specialties
Internal Medicine
Licenses
Internal Medicine in OR
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

2700 Se Stratus Ave, Suite 403, Mcminnville, OR 97128

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study
Enrollment Status: Completed
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Mesenchymal Stromal Cell-Coated Anal Fistula Plug
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Other, Drug
Study Drugs: Methotrexate, Ondansetron
Study Phase: Phase 3
View 3 Less Clinical Trials

27 Total Publications

Educational interventions improve disparities in patient access to kidney transplantation: a network meta-analysis of randomized controlled trials.
Educational interventions improve disparities in patient access to kidney transplantation: a network meta-analysis of randomized controlled trials.
Journal: International journal of surgery (London, England)
Published: July 30, 2024
Similar Doctors
Experienced in Erythema Multiforme
Dr. Elizabeth G. Liles
Internal Medicine
Experienced in Erythema Multiforme
Dr. Elizabeth G. Liles
Internal Medicine

Kaiser Permanente Tanasbourne Region Call Center

3175 NE Aloclek Dr, 
Hillsboro, OR 
 (27.2 miles away)
800-813-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Elizabeth Liles is a primary care provider, practicing in Internal Medicine in Hillsboro, Oregon. Dr. Liles is rated as an Experienced provider by MediFind in the treatment of Erythema Multiforme. Her top areas of expertise are Bell's Palsy, Tetanus, Shingles, Colorectal Cancer, and Colonoscopy. Dr. Liles is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stephens's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile